Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis

Excerpts from the publication

Background: Psilocybin, a naturally occurring psychedelic compound found in certain species of mushrooms, is known for its effects on anxiety and depression. It has recently gained increasing interest for its potential therapeutic effects, particularly in patients with advanced cancer. This systematic review and meta-analysis aim to evaluate the effects of psilocybin on adult patients with advanced cancer.

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)

Lifetime use of psychedelics is associated with better mental health indicators during the COVID-19 pandemic

The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression

Psychedelic-Assisted Therapy for People with Eating Disorders

Subjective ibogaine experiences across intersecting social-ecological dimensions